FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9564911000001102: Erlotinib 150mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31141101000001114 Erlotinib 150mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
31141201000001119 Erlotinib 150mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

9 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erlotinib 150mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Is pack of Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has active ingredient Erlotinib false Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has active ingredient Erlotinib hydrochloride false Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has active ingredient Erlotinib hydrochloride false Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has VMP Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erlotinib true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has specific active ingredient Erlotinib hydrochloride true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets 30 tablet Has basis of strength substance Erlotinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erlotinib 150mg tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (Amarox Ltd) 30 tablet 3 x 10 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Tarceva 150mg tablets (Roche Products Ltd) 30 tablet Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (Sandoz Ltd) 30 tablet 3 x 10 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (Zentiva Pharma UK Ltd) 30 tablet 5 x 6 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (Viatris UK Healthcare Ltd) 30 tablet 3 x 10 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (Accord Healthcare Ltd) 30 tablet 3 x 10 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier
Erlotinib 150mg tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Is a True Erlotinib 150mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start